中国经济网北京9月22日讯 锦盛新材（300849.SZ）近日披露2025年半年度报告。2025年上半年，公司实现营业收入1.51亿元，同比下降9.33%；归属于 上市公司股东的净利润为-879.65万元，上年同期56.25万元；归属于上市公司股东的扣非净利润为-1094.79万元，上年同期为-747.96万元；经营活动产生的现 金流量净额为-550.07万元，上年同期为279.00万元。 | | 本报告期 | 上年同期 | 本报告期比 | | --- | --- | --- | --- | | 营业收入(元) | 150,980,934.64 | 166, 509, 935. 68 | | | 归属于上市公司股东的净利润(元) | -8.796.537.52 | 562, 456. 99 | | | 归属于上市公司股东的扣除非经常性 损益的净利润(元) | -10, 947, 893. 39 | -7, 479, 580. 08 | | | 经营活动产生的现金流量净额(元) | -5.500.662.92 | 2.789.970.84 | | | 基本每股收益(元/股) | -0. 0586 | 0. 00 ...

锦盛新材证券部相关人士在接受《中国经营报》记者采访时表示："目前该事件未对公司正常运转造成 影响。" 9月12日晚间，锦盛新材（300849.SZ）发布公告称，公司及相关人员于近日收到中国证券监督管理委员 会浙江监管局出具的警示函。此前，浙江证监局在现场检查中发现锦盛新材存在混同管理实控人控制企 业、未及时披露关联交易等多项违规问题。 中经记者 陈家运 北京报道 值得注意的是，今年6月27日，锦盛新材还因涉嫌信息披露违规违法，被证监会立案。短时间接连引发 监管关注，公司内部控制和合规管理状况，引发市场关注。 多项违规 8月25日晚间，锦盛新材发布2025年半年度报告。报告期内，公司实现营业收入1.51亿元，同比下降 9.33%；归属于上市公司股东的净利润为-879.65万元，同比下降1663.95%；扣除非经常性损益后的净利 润为-1094.79万元，同比下降46.37%。 财报显示，上半年锦盛新材内销较上年同期减少846.89万元，同比下降7.30%，外销较上年同期减少 706.01万元，同比下降13.98%。公司解释称，内销收入下降主要系部分玻璃瓶业务净额法核算影响，外 销收入下降则主要受宏观环境影响。 ...

Group 1 - The company received a warning letter from the Zhejiang Securities Regulatory Bureau due to issues related to the improper use of raised funds, failure to disclose related party transactions in a timely manner, and inaccuracies in periodic reports [1] - The company is committed to addressing the issues highlighted in the warning letter by enhancing internal compliance and improving the quality of information disclosure to protect shareholder interests [1] Group 2 - The company specializes in the research, production, and sales of cosmetic plastic packaging containers, with key products including cream jars and lotion bottles [2] - The company's IPO fundraising projects included a technical transformation project to increase production capacity by 15 million sets of cosmetic packaging containers and a new project to produce 45 million sets, utilizing funds of 92.22 million yuan and 200.63 million yuan respectively [2] - The company has fully utilized its IPO funds by the end of 2023, and all fundraising accounts have been closed [2] Group 3 - The company has established stable and long-term relationships with well-known cosmetic brands such as Estée Lauder and Shanghai Jahwa, leveraging its product quality and management capabilities to attract high-end clients [3] - The global cosmetic packaging market is projected to grow from 30.055 billion USD in 2024 to 36.206 billion USD by 2028, indicating strong growth potential driven by demand for personalized and high-end designs [3] - The rise of domestic brands through social e-commerce platforms like Douyin presents structural growth opportunities for domestic cosmetic packaging companies, which may further expand the company's development space as its fundraising projects come online [3]

Core Insights - KKR has acquired South Korean cosmetics packaging company Samhwa from TPG for 733 billion KRW (approximately 528 million USD) [1] - This acquisition continues KKR's long-term investment strategy in South Korean enterprises, having previously invested in companies like Musinsa, SK E&S, and Ecorbit [1] - Samhwa aims to leverage KKR's global network to enhance collaborations with major luxury brands [1] Company Overview - Samhwa, established in 1977, initially focused on mold development and manufacturing, and now provides packaging solutions for over 300 cosmetic brands, including L'Oréal, Estée Lauder, and Chanel [1] - TPG has been investing in Samhwa since 2023 [1] Industry Context - The acquisition occurs at a time when the South Korean cosmetics industry is gaining global recognition and becoming one of the top cosmetic exporting countries [1]

Group 1 - The core point of the article is that Jinsheng New Materials (SZ 300849) held its third board meeting on August 25, 2025, to review the proposal for amending the "Rules of Procedure for Special Committee Meetings" [1] - For the fiscal year 2024, the company's revenue composition is entirely from cosmetic packaging, accounting for 100.0% [1]

Core Viewpoint - The recent investigation by the China Securities Regulatory Commission (CSRC) into Jinsong New Materials highlights a significant trust crisis for the company, stemming from long-standing operational issues, including continuous losses, high customer concentration, and industry challenges [1]. Group 1: Operational Challenges - Jinsong New Materials reported a revenue of 333 million yuan in 2024 but incurred a net loss of 22.65 million yuan, continuing into Q1 2025 with a loss of 3.836 million yuan [2]. - The company's heavy asset model, with a 66,000 square meter factory and over 900 employees, has become a burden due to increased depreciation amid fluctuating orders [2]. - The reliance on major clients like L'Oréal and Estée Lauder has led to a precarious revenue model, exposing the company to risks from exchange rate fluctuations and tariff policies, as 50% of its business is based on FOB settlements [2]. Group 2: Governance Issues - The CSRC's investigation reveals deep governance issues within the company, particularly the concentrated ownership structure, with the controlling family holding 23.11% of voting rights, raising concerns about internal control failures [3]. - The lack of transparency regarding specific violations and the frequent "normal operations" announcements amid ongoing losses have led to market skepticism about the company's financial health [3]. - Following the investigation announcement, the company's stock experienced a single-day volatility exceeding 16%, indicating a loss of investor confidence and increased financing difficulties [3]. Group 3: Industry Context - Jinsong New Materials represents a failed case in the transformation of Chinese manufacturing, focusing too much on its status as a leading acrylic container producer while neglecting core process control and innovation [4]. - The company faces increasing competition from both established brands and new entrants in the cosmetics packaging sector, which could easily replace Jinsong as major clients build their own packaging facilities [4]. - Without a shift from being perceived as a mere contract manufacturer to a developer of materials and ESG standards, Jinsong New Materials may face escalating operational challenges [4].

Core Viewpoint - The company, primarily engaged in the production and sales of cosmetic packaging containers, has faced significant challenges post-IPO, including declining revenues and profits due to the pandemic and underutilized production capacity [1][3]. Group 1: Financial Performance - The company's revenue and net profit showed strong growth before its IPO, with net profit nearly tripling from 2015 to 2019 [1]. - Post-IPO, the company has not recovered to pre-IPO revenue levels, with net profit experiencing three consecutive years of losses [1]. - The gross profit margin has declined significantly, dropping from over 35% before the IPO to less than half in the second year post-IPO [6]. Group 2: Production Capacity and Utilization - The company has a total production capacity of 11.4 million sets, including a new project that added 4.5 million sets, but production volumes have been significantly lower, with utilization rates of approximately 58.2% in 2021 and 45% in 2022 [3][4]. - In 2024, despite an increase in order volume, the production capacity utilization rate was only 71% [3]. Group 3: Expansion Projects and Related Transactions - The company has faced setbacks in its expansion plans, including the termination of a project aimed at increasing production capacity by 1.5 million sets [8]. - A new project to produce 6 million sets has been initiated, with an investment of 299 million yuan, but it has not yet resulted in operational machinery [8]. - The project involves a related party transaction, raising concerns about governance and potential implications for the ongoing investigation by the regulatory authority [8]. Group 4: Financial Anomalies - There has been a notable increase in short-term borrowings, which rose by 54.34% year-on-year, raising flags about potential financial irregularities [9]. - The company has explained the increase in borrowings as a response to business planning needs, although the related subsidiary has not engaged in substantial business activities [10][11].